Despite the wide application of radiation in
diagnostics and treatments, there is still no magic material to
protect people from radiation exposure. Though Amifostine is
developed as a radioprotectant, the FDA approved its application
only for the protection of salivary glands. Also it requires
repetitive injections to be effective and it can pose severe health
threats of systemic toxicity and complications when applied to
those under total body irradiation conditions.